Haupt Pharma Wolfratshausen GmbH
FDA inspection history in Wolfratshausen, Germany, 2012
- 1
- Form 483
Every document, by year
- Form 483
2012: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2012One Form 483, at Wolfratshausen, Germany.
Cited most
Across all Haupt Pharma Wolfratshausen observations on file
- 21 CFR 211.42Design and construction features2
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures2
- 21 CFR 211.100Written procedures; deviations1
The complete Haupt Pharma Wolfratshausen file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Wolfratshausen, Germany
One Form 483 · 2012 · 5 observations
Latest: Form 483, May 11, 2012 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2012-05-11 | 483 Form 483 | Wolfratshausen, Germany | 5 | $99 |
Investigators on these documents
FEI number 3000310230 · most recent document May 11, 2012
About Haupt Pharma Wolfratshausen GmbH
How many FDA Form 483s has Haupt Pharma Wolfratshausen GmbH received?
FDA Intel has 1 Form 483 on file for Haupt Pharma Wolfratshausen GmbH; the most recent is dated May 11, 2012.
When was Haupt Pharma Wolfratshausen GmbH last inspected by FDA?
The most recent FDA inspection document on file for Haupt Pharma Wolfratshausen GmbH is a Form 483 dated May 11, 2012, for the site in Wolfratshausen, Germany.
What did FDA cite at Haupt Pharma Wolfratshausen GmbH?
The regulations cited most in the observations on file for Haupt Pharma Wolfratshausen GmbH are 21 CFR 211.42 (Design and construction features), 2 times; 21 CFR 211.84 (Testing and approval or rejection of components, drug product containers, and closures), 2 times; 21 CFR 211.100 (Written procedures; deviations), 1 time.